Background-Despite improvement in short-term patient survival after heart transplantation (HTx), long-term survival rates have not improved much, mainly because of cardiac allograft vasculopathy (CAV). Cytokines and chemokines are considered to play an important role in CAV development. Methods and Results-We focused on coronary arteries of HTx patients and made an inventory of the infiltrating cells and the expression of cytokines as well as chemokines and chemokine receptors (CϩCR) in the different layers of the vessel wall with CAV. Tissue slides were stained for a variety of cell markers (CD3, CD4, CD8, CD20, CD68, CD79a), chemokines (monokine induced by interferon [MIG], interferon-inducible protein 10 [IP-10], interferon-inducible T cell-␣ chemoattractant [ITAC], RANTES [regulated on activation normal T cell expressed and secreted], and fractalkine), and chemokine receptors (CXCR3, CCR5, and CX3CR1). In reference coronary arteries (not transplanted), almost no infiltrating cells were found, and in transplanted hearts with CAV (HTxϩCAV), a large number of T cells were observed (CD4:CD8ϭ2:1), mainly localized in the neointima and adventitia. Most of these T cells appeared to be activated (human leukocyte antigen DR positive). Coronary arteries from transplanted hearts without CAV (HTxϪCAV), HTxϩCAV, and references were also analyzed for cytokine and CϩCR mRNA expression with the use of quantitative polymerase chain reaction. Interferon-␥ was highly expressed in HTxϩCAV compared with HTxϪCAV.
cell-␣ chemoattractant (ITAC), and IFN-inducible protein 10 (IP-10). 10, 11 These chemokines and others such as RANTES (regulated on activation normal T cell expressed and secreted) and fractalkine are directly linked with CAV development in animal studies. [12] [13] [14] Studies for the role of chemokines in human CAV development are limited to 2 immunohistochemical investigations 15, 16 and studies on human coronary arteries transplanted in severe combined immunodeficiency mice reconstituted with human peripheral blood mononuclear cells (PBMCs). 17, 18 CAV develops in rodents as early as 14 days after transplantation, 12 but its course in humans is relatively slow. Extrapolation of animal studies to the human situation seems treacherous and requires confirmation in human arteries. To obtain a better insight into the relation between infiltrating cells and CAV development, an inventory was made of infiltrating cells, cytokines, and chemokines and chemokine receptors (CϩCR) in coronary arteries obtained from HTx patients at postmortem examination with the use of immunohistochemistry and quantitative polymerase chain reaction (PCR).
Methods

Patients
Patient and coronary artery characteristics are summarized in Table  1 . All patients were treated with a standard triple immunosuppressive therapy of cyclosporin A, azathioprine, and steroids. All coronary arteries were obtained at autopsy. Informed consent of all patients was obtained before transplantation. The HTx patients were subdivided into a group that developed severe CAV (nϭ8) and a group that did not (nϭ7). The severity of CAV was determined by the degree of intima thickening, amount of infiltrate, and degree of lumen occlusion. If the ratio [intima/(intimaϩlumen)] exceeded 50%, CAV was diagnosed (measurements were performed at 3 different positions in the vessel wall).
Histology
For routine pathology, all coronary arteries were analyzed with the use of hematoxylin-eosin (HE) or elastica van Gieson staining for detection of the lamina elastica. The total number of infiltrating leukocytes per area was determined with the use of a grid that corresponds to 10 000 m 2 . The mean amount of cells was determined at 5 different places in the same area.
Immunohistochemistry
Immunohistochemistry was performed as previously described by de Jonge et al. 19 Briefly, 4-m slides were cut from formalin-fixed, The coronary artery characteristics varied as follows: *coronary arteries with (ϩ) or without (Ϫ) CAV; †coronary artery tissue with atherosclerotic plaques (A); ‡coronary arteries paraffin embedded and used for immunohistochemistry (P) or frozen in liquid nitrogen and used for mRNA analysis (F).
§Multiple coronary arteries were used from this patient, either after different tissue preservation or from different locations.
paraffin-embedded coronary arteries. The tissue slides were deparaffinized and rehydrated by subsequent washing in xylene, 100% EtOH, 70% EtOH, and distilled water, all for 5 minutes. Subsequently, endogenous peroxidase activity was blocked. Immunohistochemical procedures varied per antibody used; pretreatment, type of antibody, and procedure are summarized in Table 2 .After incubation, all slides were stained with diaminobenzidine. Standard controls (isotype controls and controls that leave out the primary antibody) were tested on parallel tissue specimens. For control, all CϩCR and marker antibodies were tested and titrated on lymphoid tissues 19 (data not shown).
mRNA Isolation
mRNA was extracted from frozen sections of whole coronary arteries and isolated with the use of magnetic oligo(dT) beads (GenoPrep mRNA beads; GenoVision, Valencia, Calif), according to the manufacturer's instructions. The mRNA was stored at Ϫ80°C.
cDNA Synthesis
One microliter of oligo(dT)(15) primers (0.50 g; Promega Corporation, Phoenix, Ariz) and 1 L of random primers (0.50 g; Promega) were added to 18 L mRNA derived from the mRNA isolation. This solution was heated in a closed Eppendorf tube for 5 minutes at 70°C, and the tube was cooled down to room temperature. Then 16 L ribonuclease-free water, 12 L 5X RT buffer (Invitrogen Corporation, Carlsbad, Calif), 6 L 0.1 mol/L dithiothreitol, and 4 L deoxy nucleotide triphosphate were added. After vigorous mixing, 1 L RNasin (Promega) was added and mixed again, and finally 1 L SuperScript RNase H-Reverse Transcriptase (Invitrogen) was added and heated in a closed Eppendorf tube for 1 hour at 42°C. The cDNA was stored at Ϫ20°C.
Real-Time Quantitative PCR
To study the expression levels of CϩCR and cytokines, primer/probe combinations were custom-made by Applied Biosystems (Foster City, Calif). Per well, 12.5 L Taqman Universal Master Mix was used, and 1.25 L primer per probe, 6.25 L Milli-Q, and 5 L cDNA sample were added. The quantitative PCR reactions were performed by the Prism 7700 sequence detection system (Applied Biosystems). Thermal cycling constituted a denaturation step at 95°C for 10 minutes, followed by 45 cycles of 95°C for 15 seconds and 60°C for 60 seconds. All experiments were performed in duplicate; when the difference between duplicate experiments exceeded a mean threshold cycle (Ct) value of 0.8 (2ϫSD of all duplicates), the data were rejected and repeated.
To quantify the data, the comparative Ct method was used. Relative quantity was defined as 2 Ϫ ⌬⌬ Ct , in which ⌬CtϭCt (target)ϪCt (reference), ⌬⌬Ctϭ⌬Ct (sample)Ϫ⌬Ct (calibrator). As reference, we used the gene PBGD, a housekeeping gene stably expressed in heart tissue. 19 The calibrator was a batch placental mRNA used for normalization.
Laser Tissue Microdissection
Frozen tissue sections of 10 m were cut on PEN-foil-mounted glass slides (PALM Microlaser Technologies, Bernried, Germany). The sections were air dried, stained with HistoGene Staining Solution (Arcturus, Mountain View, Calif), and rinsed with Milli Q water. From the coronary arteries, several layers were microdissected with the use of the Robot-Microbeam (Palm Microlaser Technologies), and mRNA was isolated.
Statistical Analysis
Quantitative PCR statistical analysis was performed with the use of the Mann-Whitney test (Prism GraphPad Software, San Diego, Calif). Correlation analysis was performed with Spearman correlation coefficients with the use of Prism. PϽ0.05 was considered statistically significant.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results
Cardiac Allograft Vasculopathy
Coronary arteries in normal individuals and in cardiac transplant recipients without CAV (HTxϪCAV) contain an intima defined as a cellular layer (between endothelium and lamina elastica interna), mainly composed of SMCs (Figure 1a and 1b). The different bridges were biotinylated goat anti-rabbit IgG (Go␣RaBIO; Vector, Burlingame, Calif), biotinylated horse anti-mouse IgG (Ho␣MoBIO; Vector), or horseradish peroxidase-labeled rabbit anti-goat IgG (Rb␣GoPO; Dako, Carpinteria, Calif). All cell markers used peroxidase-labeled (PO) streptavidin (Immonotech, Fullerton, Calif) as a secondary antibody. Other secondary antibodies used were rabbit or mouse powervision (PV; Klinipath, Duiven, the Netherlands). Origin of primary antibodies: R&D Systems, Minneapolis, Minn; Carpalogics, Hardwick, Mass; Santa Cruz Biotechnology Inc, Santa Cruz, Calif; Peprotech, Rocky Hills, NJ; Dako Corp, Carpinteria, Calif; Novocastra Laboratories Ltd, Newcastle, UK. Controls were performed as previously described. 19, 20 van Loosdregt et al Th1 Expression in Cardiac Allograft Vasculopathy (Figure 1c ). The other layer, next to the endothelium (area 2a), contains no SMCs but is composed of loose connective tissue, which is positive for anti-collagen type I (as is the total neointima; Figure 1d ). Most infiltrating cells in the neointima were localized in area 2a, at the border of area 2a and 2b, or just beneath the endothelium. Many infiltrating cells were also observed in the adventitia. Signs of immigration of MNCs were observed at the site of the lumen of the coronary arteries in between the endothelial cells (Figure 2e and 2f) but also in the blood vessels in the adventitia (Figure 2e ).
In some coronary arteries atherosclerosis was observed, which was defined as focal lesions, more asymmetrical than in CAV, with or without a lipid core or calcification and with interruption of the lamina elastica interna. The infiltrates associated with atherosclerosis were predominantly located in the shoulder of the lesion. These areas with atherosclerosis are described separately.
Immunohistochemistry
Cell Markers and Cell Composition of Infiltrate
Because reference and coronary arteries without CAV contained few if any infiltrating cells, these were not analyzed by immunohistochemistry. For the evaluation of the infiltrating cells in HTxϩCAV vessels, 8 paraffin-embedded coronary arteries were studied. A comparison was made between infiltrating cells in atherosclerotic plaques, infiltrating cells in the myocardium of the same allografted hearts, extravascular accumulations of MNCs (area 6), and infiltrating cells in the HTxϩCAV coronary arteries ( Table 3) .
All immunohistochemical data are summarized in Table 3 and partly illustrated in Figure 2 . The majority of infiltrating cells were CD3 ϩ , and the CD4/CD8 ratio was Ϸ2. The percentage (indicated as percentage of total leukocytes) of B cells (CD20) was low (5% to 15%) in HTxϩCAV vessels, except for the MNCs surrounding the coronary arteries (area 6); these contained about the same numbers of B and T cells. In the CAV areas 1 to 4, only low percentages of macrophages (CD68) were present (8% to 15%). In addition, in the MNC accumulations in and outside the CAV vessels, only small percentages of macrophages were observed. The number of macrophages in atherosclerotic plaques was much higher (up to 50% and more) than elsewhere. Human leukocyte antigen DR (HLA-DR) expression, almost absent in reference arteries, was high in most layers of the coronary arteries and heart tissue of the transplanted heart (Figure 2d ). It was mainly expressed on infiltrating MNCs. The cell compositions in layers 1 (endothelium), 2 (neointima), and 4 (adventitia) were comparable (Table 3) .
Chemokines and Chemokine Receptors on Infiltrating Cells
The CϩCR expressions on MNCs (Table 3 ) in areas 1, 2, and 4 were comparable (indicated as percentage of total leukocytes) for RANTES (37% to 44%), MIG (29% to 37%), IP-10 (59% to 63%), ITAC (56% to 60%), fractalkine (59% to 66%), CCR5 (58% to 68%), CXCR3 (73% to 78%), and CX3CR1 (24% to 26%). The expression in area 3 (tunica media) was relatively low, as were the cell numbers. In the other areas of the CAV vessels, the composition of the CϩCR differed: MNC accumulations in the CAV vessels (area 5) showed a relatively low expression of RANTES, ITAC, CXCR3, and CX3CR1, and the mononuclear cell accumulations outside the vessels (area 6) showed relatively low RANTES, MIG, and CX3CR1 expression. In both the myocardium of the transplanted heart and in atherosclerotic plaques, the occurrence of CϩCR on infiltrating cells was low overall compared with the neointima (Table 3) .
Coronary arteries with severe atherosclerosis contained a number of infiltrating cells, especially in the shoulders of fatty plaques. These infiltrates consisted of T cells (CD4 ϩ as well as CD8 ϩ ), plus a majority of macrophages. The number of infiltrating cells in atherosclerotic plaques was low compared with CAV coronary arteries. In atherosclerotic plaques in HTxϩCAV, the infiltrates showed an expression pattern in between that of the intima of HTxϩCAV and the nontransplanted atherosclerotic plaque, suggesting a mixture of both CAV and atherosclerosis. These infiltrates were therefore not evaluated further.
Real-Time Quantitative Polymerase Chain Reaction
Data on the expression of cytokines IFN-␥, interleukin-4 (IL-4), interleukin-10 (IL-10), and transforming growth factor-␤ (TGF-␤) are shown in Figure 3a . IL-4 was weakly expressed, without significant differences between references, HTxϪCAV, and HTxϩCAV. In addition, the expression of IL-10 in these 3 groups did not differ, although it tended toward a higher expression in the HTxϪCAV compared with the HTxϩCAV group (Pϭ0. 19) . By contrast, the IFN-␥ expression in HTxϩCAV was significantly higher (Pϭ0.02) than the expression in reference vessels and HTxϪCAV. Additionally, expression of IFN-␥ was higher in HTxϪCAV than in references. TGF-␤ expression in coronary arteries after HTx was high compared with reference arteries, but coronary arteries after HTx with or without CAV did not differ significantly in this respect.
The expression of the chemokines RANTES (Pϭ0.01), ITAC (Pϭ0.002), IP-10 (Pϭ0.001), and MIG (Pϭ0.001) in HTxϪCAV was significantly higher than in references (Figure 3b ). Fractalkine expression did not differ (Pϭ0.73). In HTxϩCAV, a significantly higher expression for RANTES (Pϭ0.01), fractalkine (Pϭ0.002), and ITAC (Pϭ0.01) was observed compared with the HTxϪCAV expression. The expression of MIG (Pϭ0.41) and IP-10 (Pϭ0.11) did not reach significance between the 2 HTx groups. All chemokines were more strongly expressed in HTxϩCAV than in the reference vessels.
The expression of 4 chemokine receptors (CCR5, CCR4, CX3CR1, CXCR3) was only significantly different between the references and HTxϪCAV for CXCR3 (Pϭ0.002) and CCR4 (Pϭ0.01; Figure 3c) . The difference observed for CXCR3 (Pϭ0.055) between HTxϪCAV and HTxϩCAV staining, coronary arteries almost devoid of CD20 ϩ B cells but strong staining in area 6. c, CD3 staining, strong T-cell staining for CD3 in neointima and adventitia but also in area 6. d, HLA-DR staining, many HL-DR-positive MNCs in the infiltrate localized in the neointima. e, Lymphocyte migration from capillaries in the adventitia (arrow). f, Lymphocyte migration through the endothelium of the coronary arteries (arrow). L indicates lumen of the arteries.
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was nearly significant. A significantly higher expression for CCR5 (Pϭ0.03) and CX3CR1 (Pϭ0.001) was observed in the HTxϩCAV group compared with the HTxϪCAV group. Although in Figure 3c the expression of CCR4 seems to be lower in the HTxϩCAV group than in the HTxϪCAV group, the expression of CCR4 did not differ significantly between both HTx groups (Pϭ0.42). The chemokine receptor expression was significantly higher for all receptors between the HTxϩCAV and reference groups.
To exclude the possibility that the differences observed in CϩCR expression were related to the time after HTx, the expressions of all CϩCR in all HTx coronary arteries (both HTxϪCAV and HTxϩCAV) were plotted against time. In Figure 4 this is illustrated for CX3CR1 and CCR5; in none of the cases was a significant correlation observed. Likewise, no correlation was found between the CϩCR expressions after HTx and (acute) rejection grade (data not shown).
Laser Tissue Microdissection
With the use of laser tissue microdissection, 4 distinct layers of the coronary arteries with CAV were isolated: the neointima (area 2a and area 2b separately), the tunica media (area 3), and the adventitia (area 4). mRNA from these layers was analyzed for IFN-␥, TGF-␤, ITAC, MIG, CXCR3, CX3CR1, and CCR4. Without exception, all these genes were expressed in the neointima layer (area 2a) and the adventitia, whereas the expression levels in the tunica media and the neointima (area 2b; containing predominantly SMCs) were very low or not detectable (data not shown).
Discussion
CAV is a process that negatively affects survival after HTx. The concentric growth is generally believed to be caused by the influx and growth of SMCs originating in the tunica media of the coronary arteries. In this report we show that this neointima is composed of 2 layers: one adjacent to the lumen and composed of a loose connective tissue in which many infiltrating cells are present, and another next to the lamina elastica interna, which is composed of SMCs. A similar morphology was described by Atkinson et al. 21 Many infiltrating cells are located at the border of these 2 layers in the neointima. Clearly, the neointima of all human coronary arteries obtained from nontransplanted hearts at autopsy already contains a considerable number of SMCs. This suggests that in the process of neointima formation, as observed in human CAV, the influx of SMCs is limited and the increase of intima volume is mainly owing to formation of connective tissue (filled with MNCs). This type of intima formation seems to differ from the more rapid neointima formation in experimental animals, which mainly contains SMCs. 4, 22 Because T cells are important producers of cytokines and chemokines, we have focused on the role of T cells in the wall of coronary arteries. Most cells were present in the adventitia and in the neointima. The tunica media contained only a small number of MNCs. The cells seem to migrate from different sites. We speculate that the cells in the adventitia enter from the capillary network in the adventitia, whereas the cells in the neointima migrate directly into the arterial wall from the Mean percentages of cells positive for a specific antibody are shown. Coronary arteries with CAV were scored for 8 different areas: endothelium (area 1), neointima (area 2), tunica media (area 3), adventitia (area 4), accumulations of MNCs in the neointima (area 5), accumulations of MNCs outside the coronary artery (area 6), and MNCs in between the cardiomyocytes (heart) and the atherosclerotic plaque.
lumen of the coronary artery, through the endothelial layer. However, the composition of both populations did not differ in terms of lymphocyte subsets, chemokine production, and chemokine receptor expression (as determined by immunohistochemistry and mRNA expression after laser microdissection). This indicates that this population of cells in the blood encounters the same trigger for migration at the site of the adventitia and the neointima.
Most of the infiltrating MNC were T cells, at a CD4:CD8 ratio of Ϸ2. Because not all HLA-DR expression (45% to 55%) can be ascribed to macrophages (10% to 15%), at least part of the T cells must be HLA-DR positive (see also the morphology; Figure 2d ). Consequently, many T cells are HLA-DR positive and apparently in an activated state. The numbers of macrophages and B cells are relatively small, particularly when the numbers were compared with those in the infiltrate in atherosclerotic plaques or in extranodular MNC accumulations surrounding the coronary arteries. The former consisted mainly of macrophages; the latter contained high numbers of B cells. Compared with the infiltrating cells in the myocardium, there is a clear difference in the percentages of CD8 ϩ cells and CϩCR expression. In brief, the Chemokines and cytokines play an important role in both the process of acute heart allograft rejection 23, 24 and neointima formation, as was shown in various experimental models. 11, [25] [26] [27] Studies in human cardiac transplant recipients are scarce or fragmentary. In most human studies for CAV, heart biopsies or PBMCs were analyzed. 8, 15, 28 They have generally demonstrated an upregulation of ITAC, IP-10, and CXCR3 in CAV patients compared with controls, whereas MIG and RANTES did not change. In 2 studies, the presence of some chemokines in human CAV has been documented with the use of immunohistochemistry. 15, 16 These studies showed a higher expression of RANTES and ITAC in coronary arteries with CAV compared with references, but IP-10 and MIG were completely absent.
In the present study, high numbers of infiltrating cells expressing cytokine receptors CCR5 and CXCR3 (50% to 75%) in the intima and adventitia were observed by immunohistochemistry. CX3CR1 was expressed less prominently but still on a relatively high percentage of leukocytes (25% compared with other infiltrates at 10% to 15%). In addition, the chemokines MIG (35% to 40%), IP-10 (55% to 60%), ITAC (55% to 60%), and fractalkine (55% to 65%) were expressed on a considerable number of MNCs. MIG and CCR5 are implicated in T-cell attraction and activation in CAV, 11, [25] [26] [27] whereas CX3CR1 and IP-10 have been implicated in acute rejection in various animal studies. 24, 28 This indicates that within the neointima and the adventitia, an active infiltrate of MNCs is present with a high chemoattractant potential. Within the T-cell population, CCR5 and CXCR3 are mainly expressed on T-helper 1 (TH1) cells. 28 -32 CCR5 is also expressed on macrophages, but these are only present in low numbers. CCR5 and CXCR3 are also expressed on natural killer cells, 33 but these could not be detected in the CAV wall (data not shown). CX3CR1 can be expressed by natural killer cells, dendritic cells, and macrophages, but on T cells it is characteristic for memory cells. 29 To further evaluate the infiltrate in the arterial wall, quantitative PCR was performed. These data underscore the immunohistochemical data, a strong expression of the TH1 chemokines ITAC, MIG, and fractalkine, and a less prominent expression of RANTES and IP-10. Interestingly, the expression of all chemokines was stronger in the HTxϩCAV vessels than in the HTxϪCAV vessels. In addition, the TH1 chemokine receptors (CXCR3, CCR5, and CX3CR1) are highly expressed in the HTxϩCAV group compared with the HTxϪCAV group. Blockade of these receptors attenuates chronic rejection in experimental animals. 25, 26 Despite the low number of leukocytes in HTxϪCAV, there was a significant expression of IL-10, TGF-␤, MIG, and CCR4. This expression is most likely caused by macrophages, fibroblasts, or even SMCs.
Cytokines were not evaluated immunohistochemically because the stainings were not unequivocal. However, the quantitative PCR data showed that the TH1 cytokine IFN-␥ was significantly elevated in the HTxϩCAV group compared with the HTxϪCAV group. IFN-␥ has been indicated in various experimental and human studies as one of the most important mediators of CAV induction. 17, 18 Burns et al 30 performed similar techniques on human coronary arteries transplanted in severe combined immunodeficiency mice reconstituted with human PBMCs. They also described a major involvement of TH1 cells producing IFN-␥, which were localized mainly in the neointima or adventitia. The TH2-linked cytokine IL-4 is only expressed at low levels in all groups, and the TH0/TH2-associated cytokine IL-10 is relatively abundantly expressed in the HTxϪCAV group compared with the nontransplanted and HTxϩCAV group. Expression of TGF-␤ was significantly higher in all HTx coronary arteries compared with references, but there was no significant difference between the HTxϪCAV and HTxϩCAV groups.
In summary, coronary arteries with CAV contain an abundant T-cell infiltrate. Most T cells are CD4 ϩ and express HLA-DR. These activated T lymphocytes appear to be TH1 cells on the basis of their CϩCR profile and cytokine expression (IFN-␥ versus IL-4, CCR4); most likely they are memory cells (CX3CR1 ϩ ). 29, [31] [32] [33] A TH1 response is often associated with a strong inflammatory (cytotoxic) response. Although low numbers of TH2 cells are present, this study suggests that the activated TH1 cells in the intima are able to induce a matrix proliferative response, perhaps by activating macrophages (TGF-␤ production), which leads to an increase of the neointima. 32, 33 Disclosures None.
CLINICAL PERSPECTIVE
Cardiac allograft vasculopathy is an untreatable concentric enlargement of the intima of coronary arteries in the donor heart after heart transplantation. This intima enlargement (neointima formation) causes ischemia and finally failure of the transplanted heart. In contrast to the current opinion on cardiac allograft vasculopathy or chronic rejection, this study shows that this intima enlargement is not caused by smooth muscle cell infiltration and proliferation but is merely a volume increase caused by extracellular matrix formation (collagen I and fibroblasts). This luminal layer of the neointima is in most cases populated by a large number of T cells. These T cells have an activated helper 1 phenotype and are most likely either directly or indirectly via macrophages responsible for the induction of the intima proliferation. These data can lead to a more specific form of therapeutic approach of chronic rejection, which is an increasingly difficult problem in long-term survival of transplanted organs. The medication should therefore be directed against matrix formation rather than against smooth muscle cell infiltration and proliferation. Possible targets for this therapeutic approach may be the cytokine production of the T cells (eg, inhibition of growth factors like transforming growth factor-␤) or the infiltration of these T cells in the intima. This may explain the positive effect of medication with immunosuppressive drugs like everolimus and sirolimus.
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